(Q34299445)

1 August 2017

title

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship (English)

1 reference

1 August 2017

2

Juliette Thariat

1 reference

1 August 2017

Joel B Epstein

1

1 reference

1 August 2017

Rene-Jean Bensadoun

3

1 reference

1 August 2017

Andrei Barasch

4

1 reference

1 August 2017

Barbara A Murphy

5

1 reference

1 August 2017

Leanne Kolnick

6

1 reference

1 August 2017

Leslie Popplewell

7

1 reference

1 August 2017

Ellie Maghami

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

12 September 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

62

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

400-422

1 reference

1 August 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Current concepts in management of oral cancer--surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Transoral robotic resection and reconstruction for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Transoral robotic surgery (TORS) for base of tongue neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Transoral robotic surgery: radical tonsillectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Optimization of the temporal pattern of radiation: an IMRT based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Red shell: defining a high-risk zone of normal tissue damage in stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Dosimetric verification of RapidArc treatment delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Initial clinical experience with helical tomotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pattern of failure after helical tomotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Helical tomotherapy for head and neck squamous cell carcinoma: dosimetric comparison with linear accelerator-based step-and-shoot IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lun

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Strategies to improve radiotherapy with targeted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Clinical presentation and management of mTOR inhibitor-associated stomatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

EGFR, HER2 and VEGF pathways: validated targets for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Management of patients with advanced non-small cell lung cancer: current and emerging options

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Current status of targeted therapies for mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral complications of targeted cancer therapies: a narrative literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Patient-reported outcomes in supportive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Mucositis associated with stem cell transplantation: current status and innovative approaches to management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Xerostomia: an update for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Xerostomia: clinical aspects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Sensitivity of salivary glands to radiation: from animal models to therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The role of saliva in maintaining oral homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Preventing radiation induced xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Radiation-induced xerostomia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A systematic review of dental disease in patients undergoing cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Periodontal disease and periodontal management in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Periodontal infection in cancer patients treated with high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A systematic review of oral fungal infections in patients receiving cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Oral herpetic infections (HSV 1-8).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Zoster vaccine: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Mucocutaneous manifestations of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Varicella zoster virus: review of its management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A systematic review of bisphosphonate osteonecrosis (BON) in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Osteoradionecrosis: a new concept of its pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Efficacy of Pre- and Postirradiation Hyperbaric Oxygen Therapy in the Prevention of Postextraction Osteoradionecrosis: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Osteoradionecrosis of the mandible

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Evaluation of pain in patients with oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Orofacial pain in cancer: part II--clinical perspectives and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Orofacial pain in cancer: part I--mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A prospective, longitudinal study of pain in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Multiattribute utility assessment of outcomes of treatment for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Follow-up in patients with oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pain, quality of life, and spinal accessory nerve status after neck dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pain, function, and psychologic outcome before, during, and after intraoral tumor resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Complications of radiation therapy for head and neck cancers. The patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Review of current treatment practices for carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Quality of life and oral function following radiotherapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Orofacial pain and predictors in oral squamous cell carcinoma patients receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Pathophysiology of pain in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Using cannabinoids in pain and palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Cannabinoids in cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Topical cocaine for relief of mucosal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Recent development in therapeutics for breakthrough pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Effects of opioid rotation in chronic pain patients: ORTIBARN study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A systematic review of trismus induced by cancer therapies in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A metabotropic glutamate receptor variant functions as a taste receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The receptors and cells for mammalian taste

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Taste recognition: food for thought

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Perceived taste disturbance in adults: prevalence and association with oral and psychological factors and medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Taste Disturbance After Tonsillectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Effects of radiotherapy on olfactory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Radiotherapy-induced taste impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Irradiation impairment of umami taste in patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Long-term quality of life of patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Biology of taste buds and the clinical problem of taste loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Chronic graft versus host disease of oral mucosa: review of available therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Assessment of gustatory function by means of tasting tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Studies on the relationship between electrogustometry and sour taste perception.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Taste disorders: a survey of the examination methods and treatments used in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

A double-blind study on clonazepam in patients with burning mouth syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Taste damage: previously unsuspected consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Emerging mechanisms of immunosuppression in oral cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Post-transplant lymphoproliferative disorders of oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

High suicide risk found for patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Dosimetric Comparison of Helical Tomotherapy and Linac-IMRT Treatment Plans for Head and Neck Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Measuring Comorbidity in Patients With Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

Complete Restoration of Refractory Mandibular Osteoradionecrosis by Prolonged Treatment with a Pentoxifylline-Tocopherol-Clodronate Combination (PENTOCLO): A Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21157

21 January 2018

Identifiers

DOI

10.3322/CAAC.21157

1 reference

1 August 2017

1 reference